TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Egetis Therapeutics AB (publ)
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 21,378 | 37,295 | 42,598 |
Financial expenses | 662 | 183 | 931 |
Earnings before taxes | -183,318 | -101,952 | -187,646 |
EBITDA | -184,831 | -100,668 | -186,473 |
Total assets | 530,752 | 555,164 | 936,521 |
Current assets | 139,428 | 149,113 | 314,145 |
Current liabilities | 46,728 | 38,199 | 73,481 |
Equity capital | 478,821 | 513,980 | 659,598 |
- share capital | 10,689 | 8,473 | 9,102 |
Employees (average) | 15 | 11 | 9 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 90.2% | 92.6% | 70.4% |
Turnover per employee | 1,425 | 3,390 | 4,733 |
Profit as a percentage of turnover | -857.5% | -273.4% | -440.5% |
Return on assets (ROA) | -34.4% | -18.3% | -19.9% |
Current ratio | 298.4% | 390.4% | 427.5% |
Return on equity (ROE) | -38.3% | -19.8% | -28.4% |
Change turnover | -14,797 | -2,359 | -43,895 |
Change turnover % | -41% | -6% | -51% |
Chg. No. of employees | 4 | 2 | 0 |
Chg. No. of employees % | 36% | 22% | 0% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.